Search research articles
Contact Us
Filters
Showing results (1331-1340 of 1,504) with videos related to
Page
of 151
Sort By:
Bone Marrow Transplantation
|
December 2, 2000
Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study
H M Prince, D Rischin, G C Toner, et al.
Cytotherapy
|
May 15, 2002
Isolex 300i CD34-selected cells to support multiple cycles of high-dose therapy
H M Prince, J Bashford, D Wall, et al.
Research and Theory for Nursing Practice
|
November 17, 2020
Understanding Adolescent Expressions of Sadness: A Qualitative Exploration
Daniela A Terrizzi, Huma A Khan, Allison Paulson, et al.
Bone Marrow Transplantation
|
April 1, 1999
Ifosfamide in combination with paclitaxel or doxorubicin: regimens which effectively mobilize peripheral blood progenitor cells while demonstrating anti-tumor activity in patients with metastatic breast cancer
H M Prince, J Gardyn, M J Millward, et al.
Nature
|
December 22, 2007
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Sunitha Nagrath, Lecia V Sequist, Shyamala Maheswaran, et al.
Journal of Community Health
|
August 28, 2019
The Neighborhood as a Unit of Change for Health: Early Findings from the East Harlem Neighborhood Health Action Center
Rachel Dannefer, Barbara C Wong, Padmore John, et al.
Bioconjugate Chemistry
|
May 29, 1999
Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and properties
D L Ladd, R Hollister, X Peng, et al.
The Lancet. Respiratory Medicine
|
December 20, 2014
Individualised oxygen delivery targeted haemodynamic therapy in high-risk surgical patients: a multicentre, randomised, double-blind, controlled, mechanistic trial
Gareth L Ackland, Sadaf Iqbal, Laura Gallego Paredes, et al.
Blood Advances
|
September 8, 2021
Tumor-associated antigen-specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphoma
Hema Dave, Madeline Terpilowski, Mimi Mai, et al.
The Journal of Surgical Research
|
November 4, 2006
A bioartificial liver device secreting interleukin-1 receptor antagonist for the treatment of hepatic failure in rats
Masahiro Shinoda, Arno W Tilles, Naoya Kobayashi, et al.
Page
of 151
Search research articles
Search
Showing results (1331-1340 of 1,504) with videos related to
Sort By:
Page
of 151
Bone Marrow Transplantation
|
December 2, 2000
Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study
H M Prince, D Rischin, G C Toner, et al.
Cytotherapy
|
May 15, 2002
Isolex 300i CD34-selected cells to support multiple cycles of high-dose therapy
H M Prince, J Bashford, D Wall, et al.
Research and Theory for Nursing Practice
|
November 17, 2020
Understanding Adolescent Expressions of Sadness: A Qualitative Exploration
Daniela A Terrizzi, Huma A Khan, Allison Paulson, et al.
Bone Marrow Transplantation
|
April 1, 1999
Ifosfamide in combination with paclitaxel or doxorubicin: regimens which effectively mobilize peripheral blood progenitor cells while demonstrating anti-tumor activity in patients with metastatic breast cancer
H M Prince, J Gardyn, M J Millward, et al.
Nature
|
December 22, 2007
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Sunitha Nagrath, Lecia V Sequist, Shyamala Maheswaran, et al.
Journal of Community Health
|
August 28, 2019
The Neighborhood as a Unit of Change for Health: Early Findings from the East Harlem Neighborhood Health Action Center
Rachel Dannefer, Barbara C Wong, Padmore John, et al.
Bioconjugate Chemistry
|
May 29, 1999
Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and properties
D L Ladd, R Hollister, X Peng, et al.
The Lancet. Respiratory Medicine
|
December 20, 2014
Individualised oxygen delivery targeted haemodynamic therapy in high-risk surgical patients: a multicentre, randomised, double-blind, controlled, mechanistic trial
Gareth L Ackland, Sadaf Iqbal, Laura Gallego Paredes, et al.
Blood Advances
|
September 8, 2021
Tumor-associated antigen-specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphoma
Hema Dave, Madeline Terpilowski, Mimi Mai, et al.
The Journal of Surgical Research
|
November 4, 2006
A bioartificial liver device secreting interleukin-1 receptor antagonist for the treatment of hepatic failure in rats
Masahiro Shinoda, Arno W Tilles, Naoya Kobayashi, et al.
Page
of 151